Auriga Laboratories
Auriga files drug-delivery patent application
Published in Pharma Law Weekly, October 17th, 2006
The recent filing strengthens Auriga's business model to acquire and develop proprietary brands in the prescription drug marketplace, and then to maximize potential revenues through aggressive and broad intellectual property protection and innovative sales and marketing strategies.
The proprietary technology will be used to expand such Auriga brands as the Extendryl line, which currently comprises seven different prescription drug products. Extendryl is one of the company's...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2006-10-17)
More Articles from Pharma Law Weekly
- Aastrom Biosciences
Aastrom Biosciences provides clinical, financial update - Bioxel Pharma
Bioxel achieves key milestone in manufacturing of docetaxel - Cell Therapeutics
Cell Therapeutics announces licensing agreement with Novartis for Xyotax in treating NSCLC - Center for Addiction and Mental Health, Canada
Alcoholics Anonymous membership may decrease alcohol-related homicides - Drug Importation
Poll shows 80% of U.S. adults favor allowing importation of prescription drugs - EiRx Therapeutics
A 50% reduction in breast tumor volume size seen with Eirx lead molecule - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
